BioVie Inc.
BIVI · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $9,907 | $136,657 | $18,137 | $31,434 |
| - Cash | $24,978 | $17,545 | $23,152 | $24,406 |
| + Debt | $333 | $350 | $366 | $382 |
| Enterprise Value | -$14,738 | $119,462 | -$4,649 | $7,411 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$57 | -$57 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$5,072 | -$3,427 | -$2,931 | -$7,235 |
| % Margin | – | – | – | – |
| Net Income | -$5,131 | -$3,489 | -$2,788 | -$7,113 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.98 | -1.82 | -1.5 | -4.6 |
| % Growth | 46.2% | -21.3% | 67.4% | – |
| Operating Cash Flow | -$3,024 | -$5,607 | -$1,254 | -$8,585 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$3,024 | -$5,607 | -$1,254 | -$8,585 |